ArabFinance: The Egyptian International Pharmaceutical Industries Company (EIPICO) (PHAR) posted a 13% Year on Year decrease in its consolidated net profit for Quarter 1 (Q1) of 2020, according to the company’s May 11th financial statements filed to the Egyptian Exchange.
Consolidated net profit reached EGP 189.098 million in Q1, compared to EGP 218.314 million achieved the prior-year period.
Nevertheless, standalone net profit reached EGP 165.208 million in Q1, a 19% decline from EGP 203.316 million posted in Q1 2018.
Earlier, the company announced distributing a cash dividend of EGP 4.0655 per share on April 27th.
EIPICO is an Egypt-based public shareholding company that operates in the pharmaceutical industry. The company is a manufacturer and exporter of pharmaceuticals and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones.
Copyright © 2020 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).